Zhengnan Gao Selected Research

Zhengnan Gao Research Topics

Disease

8	Insulin Resistance 07/2022 - 04/2018
8	Neoplasms (Cancer) 01/2022 - 09/2012
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2015
7	Prediabetic State (Prediabetes) 01/2022 - 03/2014
5	Obesity 01/2022 - 03/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2014
4	Hypothyroidism 03/2019 - 01/2015
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2019
3	Overweight 01/2021 - 06/2018
2	Chronic Renal Insufficiency 11/2021 - 01/2021
2	Albuminuria 10/2021 - 01/2021
2	Kidney Diseases (Kidney Disease) 03/2021 - 01/2021
2	Abdominal Obesity 01/2021 - 03/2014
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 03/2014
2	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Alcoholism (Alcohol Abuse) 11/2021
1	Fibrosis (Cirrhosis) 11/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Fatty Liver 11/2021
1	Hyperglycemia 10/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2021
1	Myocardial Infarction 01/2021
1	Stroke (Strokes) 01/2021
1	Birth Weight (Birth Weights) 01/2020
1	Stillbirth 03/2019
1	Goiter 03/2019
1	Osteoporosis 01/2019
1	Iron Deficiencies 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Endometrial Neoplasms (Endometrial Cancer) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 03/2014
1	Lymphatic Metastasis 09/2012
1	Papillary Thyroid Cancer 09/2012
1	Neoplasm Metastasis (Metastasis) 09/2012

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2014
9	Insulin (Novolin)FDA Link 07/2022 - 03/2014
6	CreatinineIBA 07/2022 - 01/2021
6	AlbuminsIBA 07/2022 - 01/2021
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2020
3	HDL CholesterolIBA 01/2022 - 01/2021
3	CholesterolIBA 01/2022 - 03/2014
3	LipidsIBA 01/2022 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2021
2	LDL CholesterolIBA 01/2022 - 01/2020
2	ORALIT (ORS)IBA 01/2021 - 01/2020
2	Insulin Glargine (Lantus)FDA Link 01/2020 - 06/2018
2	IodineIBA 03/2019 - 04/2015
1	Alanine (L-Alanine)FDA Link 01/2022
1	glycylvalineIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Hormones (Hormone)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	SteroidsIBA 01/2022
1	VitaminsIBA 01/2022
1	AndrostenediolIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Alanine Transaminase (SGPT)IBA 11/2021
1	ElementsIBA 11/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2021
1	methyl 4-azidophenylacetimidate (APAI)IBA 05/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	EnzymesIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2018
1	Pioglitazone (Actos)FDA Link 04/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	IronIBA 01/2018
1	Iodide Peroxidase (Deiodinase)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Cadherins (E-Cadherin)IBA 09/2012
1	ezrinIBA 09/2012
1	ParaffinIBA 09/2012

Therapy/Procedure

3	Glycemic Control 11/2021 - 05/2018
1	Therapeutics 01/2020